The Utilization of Human Placental Mesenchymal Stem Cell Derived Exosomes in Aging Skin: An Investigational Pilot Study

Authors:
  • GBGreg Chernoff Bsc
    Greg Chernoff Bsc
  • MDMd
    Md
  • FRFrcsc
    Frcsc

Abstract
Introduction: The fields of cellular medicine, regenerative and stem cell therapy continue to grow, yielding many novel therapies in aesthetic and reconstructive surgery. Human placental mesenchymal stem cell - derived extracellular vesicles, or exosomes have been utilized in many degenerative, inflammatory, and autoimmune conditions involving the musculoskeletal system. Exosomes are 50-15- nm particles, rich in cytokines, messenger RNA, microRNA, and transmembrane proteins from their parent cells. They are produced by cells as a means of intercellular communication, and via a natural paracrine signaling system participate in normal bodily function. With proper homing, exosomes can illicit regenerative, ant-inflammatory, immunomodulatory, and anti-prostaglandin events. This study examines the safety and potential benefits of topically applied exosomes on aging skin. Materials and Methods: Forty patients were enrolled in a randomized, double-blinded, placebo (saline) controlled study. There were 20 patients in the treatment group and 20 patients in the saline control group. Each group underwent facial micro needling with immediate topical application of either 5 billion exosomes suspended in saline, or saline alone. Treatments were repeated at 30, 60, and 90 days, with final analysis at 120 days. Standardized photography was coupled with 3-dimentional analysis utilizing the Quantificare Imaging System (Quantificare, USA). Linear analog tests were also administered to objectify patient satisfaction. Results: There were no adverse reactions, allergic, or hypersensitivity reactions reported. The Exosome Treatment Group showed improved tone, quality, and clarity of their skin compared to the Control Group (p < .0001), with a reduction in wrinkles, pores, pigment, oiliness, and improvement in evenness of skin and vascularity. There was a constant progression of satisfaction with results in the Treatment Group from 30 to 120 days, compared with a high degree of dissatisfaction with results in the Control Group. Conclusion: Human placental mesenchymal stem cell-derived exosomes can be safely applied topically to patients with aging skin. Exosomes are a viable addition to the armamentarium of the physician treating aging skin and associated dermatopathological conditions.